Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients

J. R. Marcelin, J. W. Wilson, R. R. Razonable

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients'. Together they form a unique fingerprint.

Medicine & Life Sciences